[1]
Jagannath Dev Sharma, “Prognostic significance of evaluation of tumor infiltrating lymphocytes in triple-negative breast cancer in residual disease postneoadjuvant chemotherapy”, IJCPC, vol. 5, no. 1, pp. 13–16, Aug. 2022.